AQR Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-266,327
Closed -$35.1M 3427
2025
Q1
$35.1M Sell
266,327
-270,454
-50% -$35.7M 0.04% 562
2024
Q4
$44.8M Buy
536,781
+74,949
+16% +$6.26M 0.06% 417
2024
Q3
$33.8M Buy
461,832
+356,401
+338% +$26.1M 0.05% 476
2024
Q2
$7.22M Buy
105,431
+26,486
+34% +$1.81M 0.01% 865
2024
Q1
$5.46M Buy
78,945
+40,232
+104% +$2.78M 0.01% 940
2023
Q4
$2.77M Buy
38,713
+8,774
+29% +$628K 0.01% 1199
2023
Q3
$1.56M Buy
29,939
+13,793
+85% +$718K ﹤0.01% 1431
2023
Q2
$1.02M Buy
16,146
+2,697
+20% +$171K ﹤0.01% 1544
2023
Q1
$728K Sell
13,449
-5,542
-29% -$300K ﹤0.01% 1647
2022
Q4
$1.01M Sell
18,991
-1,354
-7% -$71.7K ﹤0.01% 1563
2022
Q3
$947K Sell
20,345
-2,702
-12% -$126K ﹤0.01% 1542
2022
Q2
$1.32M Buy
23,047
+13,222
+135% +$755K ﹤0.01% 1302
2022
Q1
$601K Buy
9,825
+1,303
+15% +$79.7K ﹤0.01% 1748
2021
Q4
$446K Hold
8,522
﹤0.01% 1860
2021
Q3
$318K Hold
8,522
﹤0.01% 2021
2021
Q2
$348K Sell
8,522
-9,872
-54% -$403K ﹤0.01% 2006
2021
Q1
$624K Sell
18,394
-14,441
-44% -$490K ﹤0.01% 1753
2020
Q4
$1.04M Sell
32,835
-18,813
-36% -$598K ﹤0.01% 1486
2020
Q3
$1.33M Sell
51,648
-10,282
-17% -$264K ﹤0.01% 1279
2020
Q2
$1.59M Buy
61,930
+616
+1% +$15.8K ﹤0.01% 1268
2020
Q1
$942K Buy
+61,314
New +$942K ﹤0.01% 1355
2019
Q1
Sell
-19,837
Closed -$226K 2229
2018
Q4
$226K Sell
19,837
-5,275
-21% -$60.1K ﹤0.01% 2045
2018
Q3
$545K Buy
25,112
+146
+0.6% +$3.17K ﹤0.01% 1927
2018
Q2
$441K Buy
+24,966
New +$441K ﹤0.01% 2020
2016
Q4
Sell
-18,864
Closed -$287K 2290
2016
Q3
$287K Buy
18,864
+1,702
+10% +$25.9K ﹤0.01% 2092
2016
Q2
$666K Sell
17,162
-3,652
-18% -$142K ﹤0.01% 1761
2016
Q1
$579K Sell
20,814
-16,042
-44% -$446K ﹤0.01% 1782
2015
Q4
$1.98M Sell
36,856
-5,572
-13% -$300K ﹤0.01% 1244
2015
Q3
$1.7M Buy
42,428
+10,327
+32% +$414K ﹤0.01% 1204
2015
Q2
$1.03M Buy
32,101
+21,201
+195% +$678K ﹤0.01% 1482
2015
Q1
$260K Buy
+10,900
New +$260K ﹤0.01% 1934